The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.

HHS announces interim policy covering six compounded peptides

Oct 30, 2026 12:32 (2h ago)

Verifying

HHS announced interim enforcement discretion for six specified compounded peptide substances.
Six peptides are covered: BPC-157, Epitalon, KPV, MOTS-c, Semax and TB-500.
CDT invested in Pep'd Inc., a U.S.-based peptide and telehealth company.